Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.

ABSTRACT:

Background

The current management of lung cancer patients has reached a high level of complexity. Indeed, besides the traditional clinical variables (e.g., age, sex, TNM stage), new omics data have recently been introduced in clinical practice, thereby making more complex the decision-making process. With the advent of Artificial intelligence (AI) techniques, various omics datasets may be used to create more accurate predictive models paving the way for a better care in lung cancer patients.

Methods

The LANTERN study is a multi-center observational clinical trial involving a multidisciplinary consortium of five institutions from different European countries. The aim of this trial is to develop accurate several predictive models for lung cancer patients, through the creation

SUBMITTER: Lococo F 

PROVIDER: S-EPMC10262371 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature